Insulin Therapy in Type 2 Diabetes
August 26, 2010 • Best Practice Series: Type 2 Diabetes, Diabetes, Endocrinology, Internal Medicine, Medical Students, Patient Education
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the use of insulin for type 2 diabetes.
Disclosures:
Speaker’s Bureau: Merck, NovoNordisk, GSK
Advisory Panel: Merck, BMS, Astra Zeneca, Boehringer Ingelheim, Biodel
Consultant: Merck, Novartis, Dainippon Sumitomo Pharma America, Forest Laboratories
Stock/Shareholder: Covidien, Bard, Novartis, Roche, Stryker
References:
Managing type 2 diabetes: balancing HbA1c and body weight
Mavian AA, Miller S, Henry RR.
Postgrad Med. 2010 May;122(3):106-17. Review.
A review of insulin pen devices
McCoy EK, Wright BM.
Postgrad Med. 2010 May;122(3):81-8. Review.
